Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the Phase 2 study of DISC-0974 in patients with myelofibrosis ...
Dr Liam O’Brien from the University of Liverpool has secured a £2.1 million EPSRC Open Fellowship to develop advanced magnetic nanoparticle tracers for next-generation medical imaging. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback